🟢 ProMIS Neurosciences is trading 9% up today in a relief bounce after Chardan initiated coverage with a Buy rating

ProMIS Neurosciences is trading at $12.78 (9% up) in after-hours trading as shares stage a relief bounce following a recent Buy rating from Chardan.

• Chardan recently initiated coverage with a Buy rating and a $20.00 price target, highlighting significant upside potential for the stock.
• With no fresh after-hours headlines or earnings releases identified, the move appears to be a reassessment of the prior bullish analyst call amid a mixed broader market backdrop.